Sugar Derivatives TRIZ Cases

Cationic base modifications on oligophosphates neutralize negative charge, reducing background noise in nanopore sequencing.

A metabolomics analysis system determines metabolic age using specific biomarker levels.

Isolated polypeptides stimulate CD4 and CD8 T cell activation to overcome viral antagonism of endogenous anti-viral proteins.

Heteroaryl inhibitors bind the myristoyl pocket to block ATP access, overcoming resistance in mutant Bcr-Abl forms.

Nucleic acid molecules encoding grg8 polypeptides transform organisms to withstand toxic herbicide levels.

Suppresses p21-mediated apoptosis inhibition using RNA interference, enabling effective p53-directed tumor cell death.

Water-soluble ligands and recyclable palladium catalysts synthesize xylose derivatives in aqueous media, reducing organic solvent waste.

Luciola italica luciferase mutants shift bioluminescence emission to red wavelengths via amino acid substitutions.

A ClorDNA virus promoter drives gene expression in algal cells to enable efficient genetic transformation.

Multimeric FcγRIIa polypeptides increase selectivity for immune complexes, reducing the dose required for effective inflammation inhibition.

Novel amphiphilic compounds stabilize membrane proteins against denaturation, enabling high-quality crystal formation for structural determination.

Targeting integration sites with extended methylation-free CpG islands prevents epigenetic silencing and ensures stable high-level protein expression.

Fluorescent proteins link gene expression levels to selectable markers, resolving heterogeneous cell population issues.

GCC technology maps three-dimensional chromatin arrangement using cross-linking and parallel sequencing.

Nucleotide sugar and backbone modifications increase guide RNA resistance to degradation while maintaining target binding affinity in eukaryotic cells.

Targeted genome mutations in recombinant chimeric flaviviruses reduce viscerotropism while maintaining immunogenicity.

Modified Fc regions reduce immunogenicity while sustaining anti-tumor immunity against cancer cells.

Optimized siRNAs target mutated CLCN7 mRNA transcripts to reduce protein expression while sparing wild-type sequences.

Compounds bind gp130 to block IL-6 signaling, addressing insufficient inhibitor potency in cancer treatment.

Incorporating unnatural nucleotides with reactive linkers into oligonucleotides via enzymatic replication.

Modified antisense compounds lower pathogenic C9ORF72 protein expression to treat neurodegenerative diseases.

A microfluidic device isolates M-Ig targeting aptamers from serum samples using integrated selection chambers.

Segmented trans-cyclooctene structures use ester linkers to resolve the trade-off between fast click kinetics and synthetic accessibility.

Targeted amino acid substitutions in antibody constant domains lower the isoelectric point, extending serum half-life while minimizing immunogenicity.

Copper-catalyzed azide-alkyne cycloaddition simplifies synthesis of modified nucleotides, enabling high-yield aptamer selection without complex equipment.

Transgenic plants produce recombinant L1, B5, and A33 proteins to provide safer smallpox vaccines for vulnerable populations.

Adjusting molar ratios, temperature, and pH during fructoborate synthesis maximizes di-complex yield while minimizing residual boric acid contamination.

Dual PI3K/Akt and MAP kinase inhibitors induce thyroid iodide-handling genes, enabling radioiodine uptake in previously refractory melanoma and thyroid cancers.

Rewiring complementarity in hairpin motifs overcomes slow assembly kinetics, enabling autonomous dynamic functions without external intervention.

Novel chimeric promoters merge tissue-selective and viral sequences to drive high transgene expression levels in targeted cells.

Adjusting alcohol levels in sequential buffers isolates short-chain nucleic acids directly from whole blood, eliminating serum separation steps.

Entangled RCA probes eliminate cross-linking steps, preventing probe loss during washing while enabling simultaneous separation and detection.

Replacing HMDS with TMSOTf in a one-pot sequence eliminates ammonia pollution and improves the beta-alpha configuration ratio during nucleoside synthesis.

Bi-functional molecules bind circulating proteins and engage hepatocyte receptors to drive intracellular degradation, reducing immunogenicity.

Genetically modified microbes overexpress GGPP synthase to increase terpenoid yields while reducing reliance on expensive chemical precursors.

High affinity antibodies target CLL-1 glycoproteins to treat hematologic malignancies while minimizing cross-reactivity with normal tissues.

A nucleic acid kit detects peripheral membrane protein binding via transcription factor fusion proteins and reporter gene expression.

Nucleoside derivatives with propyl groups enhance RNA binding affinity and thermal stability.

Engineered Sortase motifs reduce side reaction products by directing transpeptidase activity to unique amino acid sequences, improving conjugation yields.

Segmented purification using macroporous resin and preparative liquid chromatography minimizes sample loss while achieving 98% purity of acylated anthocyanins.

GelRed selectively binds dead bacteria DNA to inhibit PCR, resolving live cell detection accuracy.

The EhHOG gene confers abiotic stress resistance to transformed organisms.

Non-covalent bonding enables buffer-based detachment of ligands from biochips, preserving surface integrity for high-throughput reuse.

Primer and probe composition detects EGFR gene mutations to guide anticancer treatment selection.

Oligonucleotide probes hybridize to specific nucleic acid sequences, resolving low sensitivity and specificity in conventional microscopy diagnostics.

Standardized primer sets and protocols detect clonal rearrangements in Ig and TCR loci, resolving false positive rates in mixed lymphocyte populations.

A betaine polymer carrier captures glycopeptides via hydrophilic interaction.

Maize inbred PH2DPT applies segmentation and preliminary action to accelerate breeding development while maintaining variety stability.

Triciribine targets ovarian cancer cells through specific diagnostic identification of Akt kinase overexpression for precise therapeutic intervention.